Our biotech ETF buy has tripled the gains of the Dow since we first recommended it three-and-a-half years ago.
We expect those market-beating gains to continue because of these 4 catalysts.
by Ashley Moore
Our biotech ETF buy has tripled the gains of the Dow since we first recommended it three-and-a-half years ago.
We expect those market-beating gains to continue because of these 4 catalysts.
Not to mention, one of the stocks in the fund is set to gain as much as 178% this year...
by Ashley Moore
Start the conversation
Leave a Reply Click here to cancel reply.
You must be logged in to post a comment.
Our expert has developed a vetting process to identify the best pharmaceutical stocks to buy in 2017.
One of the stocks he picked using this set of guidelines is already up almost 60% year to date.
Here are the guidelines and the best stocks to buy now for major profits this year...
by Ashley Moore
Start the conversation
Leave a Reply Click here to cancel reply.
You must be logged in to post a comment.
The top three stocks to watch today are BDRBF, DAL, and NBIX.
Rising geopolitical tensions are causing investors to flee to safe-haven investments.
Here's what you need to know this morning...
by Ashley Moore
Start the conversation
Leave a Reply Click here to cancel reply.
You must be logged in to post a comment.
The top three stocks to watch today are SGYP, PVH, and NBIX.
The POTUS' leadership will be tested today with the House vote on Trumpcare.
Here's what you need to know this morning...
Start the conversation